US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Melodiol Global Health Ltd (ME1OD) 銘柄情報

Melodiol Global Health Ltd (ME1OD)

0.001

0.00

( 0.00% )

更新日時： 09:00:00

Melodiol Global Health Ltd (ME1OD) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.001

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.001

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 0.00

発行済株式数

13,099,868

配当利回り

PER

-0.02

1 株当たり利益 (EPS)

-11.28

歳入

18.92M

純利益

-52.45M

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business.... Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

melodiolglobalhealth.com

本社

Nedlands, Australia

設立

2026

Melodiol Global Health Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker ME1OD. The last closing price for Melodiol Global Health was AUD0. Over the last year, Melodiol Global Health shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Melodiol Global Health currently has 13,099,868 shares in issue. The market capitalisation of Melodiol Global Health is AUD13,099.87 . Melodiol Global Health has a price to earnings ratio (PE ratio) of -0.02.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

ME1OD - Frequently Asked Questions (FAQ)

What is the current Melodiol Global Health Ltd share price?

The current share price of Melodiol Global Health Ltd is AUD 0.001

How many Melodiol Global Health Ltd shares are in issue?

Melodiol Global Health Ltd has 13,099,868 shares in issue

What is the market cap of Melodiol Global Health Ltd?

The market capitalisation of Melodiol Global Health Ltd is AUD 13.1k

What is the 1 year trading range for Melodiol Global Health Ltd share price?

Melodiol Global Health Ltd has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Melodiol Global Health Ltd?

The price to earnings ratio of Melodiol Global Health Ltd is -0.02

What is the cash to sales ratio of Melodiol Global Health Ltd?

The cash to sales ratio of Melodiol Global Health Ltd is 0.12

What is the registered address of Melodiol Global Health Ltd?

The registered address for Melodiol Global Health Ltd is 145 Stirling Highway, Nedlands, Western Australia, 6009

What is the Melodiol Global Health Ltd website address?

The website address for Melodiol Global Health Ltd is melodiolglobalhealth.com

Which industry sector does Melodiol Global Health Ltd operate in?

Melodiol Global Health Ltd operates in the Pharmaceuticals sector

Huggy Bear

Huggy Bear 1分前

Surely there has to be a few more marks out there to purchase these absolutely worthless shares.

jcromeenes

jcromeenes 1分前

Surely he'll get pardoned.

Investor082

Investor082 2分前

Flipper has been playing this game for 13 years to keep bag holders on the hook. Run in the opposite direction as long as he is engaged, LOL! ;)

wiwineguy

wiwineguy 2分前

Liquefied Natural Gas (LNG) is . Valued for its high efficiency, clean burn, and low cost, it is the primary propellant for heavy-lift rockets like https://www.spacex.com/vehicles/starship and https://www.blueorigin.com/new-glenn. [https://www.linkedin.com/posts/markmaslin_stabilis-increases-lng-del

FormalMHRAconsultant

FormalMHRAconsultant 3分前

That is a solid theory lets hope they did that

Huggy Bear

Huggy Bear 5分前

Oh brother, here we go again.....

infamous

infamous 5分前

can you show me that that video from TWO WEEKS AGO did ANYTHING for the stock? hmmmm? can you? well? lets see it?

DTGoody

DTGoody 6分前

I would have too, but out of funds for the moment! Will be buying more at the end of the month!

infamous

infamous 7分前

no. everyone saw that vid already. no real time lines. even the timelines he gave is for a failed untested vehicle IMO. means very little as long as they keep diluting.

FrostyIsland3

FrostyIsland3 7分前

flipper44, what you describe is too convoluted. All NWBO needs to say is the following if it is true:

"1. The DCVax-L MAA was validated by the MHRA on March 7, 2024.

2. The DCVax-L MAA was reviewed by the OHEAG at its meeting on June 20, 2024 and was then reviewed b

CA Market News

CA Market News 8分前

H&R REIT Addresses Recent Media ReportsJune 11, 2026 8:31 PM
PR Newswire (Canada) class="legendSpanClass"TORONTO, class="legendSpanClass"June 11, 2026 /CNW/ - H&R Real Estate Investment Trust ("H&R" or "the REIT") (TSX: HR.UN) – The REIT

northam43

northam43 9分前

SPX 60 min Chart. 60 min level Current Cycle Between Cycles (CCBC) -1 (Bearish). 60-SC-1 & 5TH UPRO Buy Signal confirmed at the close of the 1ST hour. UPRO Buy Signal ended at the 5TH hour. 60-2 confirmed at the close. Next possibilities: 60-E-2 (Overdue) 7428.89, 60-S-1 (Extreme Overdue) 7332.58,

northam43

northam43 10分前

SPX 60 min Chart. 60 min level Current Cycle Between Cycles (CCBC) -1 (Bearish). 60-SC-1 & 5TH UPRO Buy Signal confirmed at the close of the 1ST hour. UPRO Buy Signal ended at the 5TH hour. 60-2 confirmed at the close. Next possibilities: 60-E-2 (Overdue) 7428.89, 60-S-1 (Extreme Overdue) 7332.58,

Eli-316

Eli-316 10分前

I received the same response.
My question is, if all filings were current, why was there a clerical error?
Did someone from OTC randomly go into the CGAC account and make a clerical error?
Just doesn’t make sense unless a filing was due and a clerical error didn’t catch the fact

Lazy Oaks

Lazy Oaks 10分前

Dude, with all due respect, you need to come to the conclusion that this guy is a 💯 fraud already.

Lve

Tomorrow should be a good day

yadotn

yadotn 14分前

MRNJ>>>Company Officers & Contacts

MRNJ
OTCMarkets
Company Officers & Contacts
https://www.otcmarkets.com/stock/MRNJ/profile

lakers17

lakers17 16分前

If Wemby gets one more flagrant he misses the next game. 29 points ahead and lose? Huge loss. If Fox pulls up and doesn't go for that blocked lay up the Spurs win. He did not need to shoot.

marzan

marzan 17分前

DAR, excellent reminder. A lot of people seem to forget that Judge Andrews’ original dismissal was not the type of ruling that slammed every door shut forever and a death sentence. It was ‘Without Prejudice’. The alleged deficiencies were in the pleadings, and Amarin was effectively given an opport

marzan

marzan 17分前

tdbowieknife

tdbowieknife 18分前

Great!... Here's the order, doesn't add anything to what you have already posted though. These guys are some of the worst that's for sure... Who the hell is buying this stock?????? Geeezzz... what idiots.

https://drive.google.com/file/d/1C4YgzYrq3Hdijw15wmCBXLwM7963VzTy/view

88TH MAN

88TH MAN 19分前

USMJ: Volume 651,325

I-Glow

I-Glow 19分前

Richard C. Hawkins has been involved in many OTC scams.

Justin Costello who recieved 12 years in Federal Prison for the scam ticker which was Renewal Fuels Inc where he owns 1,753,000,000 shares which is 59% of the company.

Of Course Richard C. Hawkins is the CEO.

Mozy429

Mozy429 19分前

Oops. Auto text got me. Meant traded higher back then, compared to now.

Melodiol Global Health

Lakeland Bancorp

International Distributi... (EM)

Hospital Mater Dei S.A ON

Structural Monitoring Sy...

DJ Industrial Average 2X...

Attica Public R

Odakyu Electric Rail (PK)

3.9638% 26/10/29 3.9638%...

ARS Pharmaceuticals

BlackRock Investment Man...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。